Stephen George Dilly, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 600 shares at $20.15 ($12K) on 2017-05-10, disclosed to the SEC on 2017-05-12.
Scheduled sale ($12k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-20 | $210K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |